The high costs of developing innovator drugs means that those treatments are often out of reach for least developed and developing countries, and even in developed countries. Affordable generics offer one major solution to this monumental problem. As such, some governments have used compulsory licensing to secure generics, if a voluntary license is not forthcoming.

However, with more patent owners recognizing that market access has shareholder value as well as patient benefits, voluntary licenses are becoming increasingly desirable.

Generics as a Vehicle to Improve Market Access summarises different approaches to providing generics as a route to improve market access and evaluates the impacts of these strategies.

Report OverviewGenerics as a Vehicle to Improve Market Access features exclusive perspectives from key people in the field of market access, including representatives from the pharmaceutical and generics industries, consultants specialising in generics and market access, and individuals from independent market access organisations, such as a voluntary licensing model.

The comprehensive report summarises the key issues around this important subject, and provides a wealth of pertinent tables, charts, and data points from sources such as the Access to Medicine Index, as well as a robust set of references, all in one convenient document.

As well as a detailed exploration of ways in which generics can improve market access, the report offers insights into other mechanisms, such as differential pricing and price-cutting, branded generics, distribution and organisational changes, and even drug donations.

Key Report FeaturesViews from branded and generic Pharma Latest definitions and data on the needs for expanded market access Up-to-date look at the impact of the TRIPS agreement Demonstrated results of generic competition Examples of compulsory and voluntary licensing agreements Voluntary licensing models - ViiV Healthcare and Medicines Patent Pool Impact of expanded access on revenues and R&D PR impact for branded and generic Pharma Role of government in securing market access Other mechanisms for improving market access

Who Would Benefit From This Report?This report will be of value to senior pharma directors and managers with responsibilities in the following areas:

Market accessLicensing Business development Marketing, brand and sales management

This report will also benefit charities working in market access, pharma consultancies, Independent voluntary licensing consultancies, state and national legislators and health policy researchers.

Key Questions AnsweredIs market access to low cost drugs just a developing world issue? Which therapeutic areas are most critical? How does intellectual property affect market access? Why do generics improve market access? Why is compulsory licensing needed? Does expanded access affect revenues and reinvestment into R&D? What is the PR impact of voluntary licensing? Which models for improving access will be the most effective?

Key BenefitsReceive clear definitions of the key issues (e.g., which countries are “least developed”?) Gain insights into the perspectives of generics companies and big pharma Learn about companies who support voluntary licensing agreements Find out which companies have compulsory and voluntary licensing agreements in place, and for which drugs Understand the PR value of voluntary licensing and other routes to expanded market access Review other mechanisms to improve access, such as differentiated pricing Hear what industry thought-leaders think are the answers to improving market access For more information kindly visit : Generics as a Vehicle to Improve Market Access

Bharat Book Bureau, the leading market research information aggregator provides market research reports, company profiles, country reports, newsletters, and online databases for the past twenty four years to corporate, consulting firms, academic institutions, government departments, agencies etc., globally, including India. Our market research reports help global companies to know different market before starting up business / expanding in different countries across the world.